Who we are
Access Hope CRO is the first CRO founded exclusively to facilitate Right to Try Treatment programs at scale for the biopharmaceutical industry. We can design, recruit, and manage sites and patients for Right to Try compliant expanded access treatment programs under the new Right to Try legislation; as well as collect observational and Real World data with our extremely cost efficient custom eCRF system.
What we do
Empower Patients & Doctors
We work with clients who are developing drugs and biologics for marketing approval in the U.S. for life threatening or severely debilitating diseases. We help them create Right to Try opportunities to make their therapies available to enhance their understanding of the drug and their treatment population to accelerate the drug development timeline.
Through our unique patient facing portal and “opt in” database, we give patients, their caregivers and their doctors the opportunity to learn about the availability of these programs.
Patients diagnosed with life threatening diseases, as well as their family and caregivers expect and deserve honest, straightforward communication. At Access Hope CRO we take this responsibility very seriously, and so we want you to know exactly what we do, and what we don’t do.
Right to Try creates heretofore unthinkable flexibility, legal immunity, and time and cost reductions while creating new data. In addition it gives you truly exclusive control over your data.